Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials

Project description

Precision medicine at the forefront of cancer care

In the EU, cancer has a devastating impact on millions; the staggering mortality rates make it a leading cause of death and morbidity. In this context, the EU-funded PRIME-ROSE project is committed to the Mission Cancer goal. Specifically, it aims to optimise treatments and enhance the quality of life for over 3 million people by 2030. In addition to enhancing access to affordable, life-prolonging treatments, the project will conduct precision cancer medicine trials and bridge gaps in healthcare inequalities. PRIME-ROSE relies on drug rediscovery protocol-like trials, ensuring a bottom-up, clinician-driven approach to bring precision medicine to the forefront of cancer care.

Objective

Millions of people in the EU are negatively affected by cancer, and cancer is one of the leading causes of death and morbidity in Europe (ecis.jrc.europa.eu). The PRIME-ROSE consortium will contribute to the Mission Cancer goal to optimise treatment and support quality of life of more than 3 million people by 2030.

The PRIME-ROSE consortium envisions to support Mission Cancer through the following objectives: 1) increase access to optimised and affordable treatment interventions for cancer patients that prolong life and increase quality of life, 2) generate clinical evidence and evaluate effectiveness in Precision Cancer Medicine (PCM)-relevant and synthetically randomised, controlled academic investigator-initiated pragmatic clinical trials, and 3) work together across Europe with relevant experts to implement evidence-based PCM in routine practice and address inequalities in access.

This consortium builds on the truly bottom-up, clinician-initiated family of DRUP-like innovative trials that provide broad access to precision medicine for cancer patients.

This action is part of the Cancer Mission cluster of projects on ‘Diagnosis and treatment’.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-RIA - HORIZON Research and Innovation Actions

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) HORIZON-MISS-2022-CANCER-01

See all projects funded under this call

Coordinator

OSLO UNIVERSITETSSYKEHUS HF
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 1 803 475,00
Address
KIRKEVEIEN 166 TARNBYGGET
0450 OSLO
Norway

See on map

Region
Norge Oslo og Viken Oslo
Activity type
Higher or Secondary Education Establishments
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 1 803 475,00

Participants (9)

Partners (18)

My booklet 0 0